Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Journal of Arthropod-Borne Diseases
|
April 11, 2023
Bionomics of <i>Anopheles culicifacies</i> Sensu Lato in two Malaria Endemic Districts of Central Gujarat, India
Rajendra K Baharia, Jaspreet Kaur, Ankita Sindhania, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
February 12, 2008
Simulation of dose to surrounding normal structures in tangential breast radiotherapy due to setup error
Ramachandran Prabhakar, Goura K Rath, Pramod K Julka, et al.
Technology in Cancer Research & Treatment
|
March 23, 2007
Comparison of contralateral breast dose for various tangential field techniques in clinical radiotherapy
R Prabhakar, P K Julka, M Malik, et al.
Kathmandu University Medical Journal (KUMJ)
|
August 29, 2024
Public Awareness and Attitude towards COVID-19 Infection and Vaccines: A cross-sectional national survey in Nepal
S Pant, S Bhattarai, K Ranabhat, et al.
Journal of Medical Physics
|
January 11, 2011
Impact of different breathing conditions on the dose to surrounding normal structures in tangential field breast radiotherapy
Ramachandran Prabhakar, Ganesh Tharmar, Pramod K Julka, et al.
Cancer Chemotherapy and Pharmacology
|
June 12, 2017
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
Howard A Burris, C D Kurkjian, L Hart, et al.
Acta Cytologica
|
August 5, 1999
Solitary nodular goiter. Review of cytomorphologic features in 441 cases
D K Das, C M Khanna, R P Tripathi, et al.
International Journal of Hematology
|
July 1, 1996
Cytogenetic and molecular genetic studies on Indian patients with chronic lymphocytic leukemia
T S Kumaravel, D Chendil, M Arif, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2014
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
S Pant, M Saleh, J Bendell, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 4, 2014
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression
D Li, S Pant, D P Ryan, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Journal of Arthropod-Borne Diseases
|
April 11, 2023
Bionomics of <i>Anopheles culicifacies</i> Sensu Lato in two Malaria Endemic Districts of Central Gujarat, India
Rajendra K Baharia, Jaspreet Kaur, Ankita Sindhania, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists
|
February 12, 2008
Simulation of dose to surrounding normal structures in tangential breast radiotherapy due to setup error
Ramachandran Prabhakar, Goura K Rath, Pramod K Julka, et al.
Technology in Cancer Research & Treatment
|
March 23, 2007
Comparison of contralateral breast dose for various tangential field techniques in clinical radiotherapy
R Prabhakar, P K Julka, M Malik, et al.
Kathmandu University Medical Journal (KUMJ)
|
August 29, 2024
Public Awareness and Attitude towards COVID-19 Infection and Vaccines: A cross-sectional national survey in Nepal
S Pant, S Bhattarai, K Ranabhat, et al.
Journal of Medical Physics
|
January 11, 2011
Impact of different breathing conditions on the dose to surrounding normal structures in tangential field breast radiotherapy
Ramachandran Prabhakar, Ganesh Tharmar, Pramod K Julka, et al.
Cancer Chemotherapy and Pharmacology
|
June 12, 2017
TAK-228 (formerly MLN0128), an investigational dual TORC1/2 inhibitor plus paclitaxel, with/without trastuzumab, in patients with advanced solid malignancies
Howard A Burris, C D Kurkjian, L Hart, et al.
Acta Cytologica
|
August 5, 1999
Solitary nodular goiter. Review of cytomorphologic features in 441 cases
D K Das, C M Khanna, R P Tripathi, et al.
International Journal of Hematology
|
July 1, 1996
Cytogenetic and molecular genetic studies on Indian patients with chronic lymphocytic leukemia
T S Kumaravel, D Chendil, M Arif, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2014
A phase I dose escalation study of oral c-MET inhibitor tivantinib (ARQ 197) in combination with gemcitabine in patients with solid tumors
S Pant, M Saleh, J Bendell, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 4, 2014
A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocarcinoma and negative tumor hENT1 expression
D Li, S Pant, D P Ryan, et al.
Page
of 12